1. Search Result

Search Result

Results for "737789-87-6" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-16474
    Relugolix

    TAK-385

    GNRH Receptor Cancer
    Relugolix is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist with IC50 of 0.33 nM in the presence of 40% fetal bovine serum, TAK-385 possesses higher affinity and potent antagonistic activity compared with TAK-013.